News
Search EMA's news announcements
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Resultaten (3808)
Measures to facilitate quicker processing of variations
NewsHumanRegulatory and procedural guidance
Uplizna significantly reduced the number of flares in patients with active immunoglobulin G4-related disease
NewsHumanMedicines
14 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications
NewsHumanMedicines
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
NewsVeterinaryMedicinesVaccines
Board’s decision concludes renewal process
NewsCorporate
Review will assess risk of leukoencephalopathy, a condition affecting the brain
NewsHumanMedicinesReferrals
PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections
NewsHumanPharmacovigilance
Illegal medicines marketed as GLP-1 receptor agonists for weight loss and diabetes pose serious risk to health
NewsHumanMedicines
Key partnership leverages EMA’s scientific expertise and WHO’s mandate to improve access to safe and effective medicines worldwide
NewsHumanCorporateMedicines for use outside the EU
The European Medicines Agency's (EMA) office is closed from 18:00 on 14 August 2025 to 08:30 on 18 August 2025
NewsCorporate